Frank Cammisa, MD

About Frank Cammisa, MD

Frank Cammisa, MD is a director at Spine BioPharma.

Frank Cammisa, MD first appears on SEC filings in 2022.

Experience

This experience comes from SEC filings. The years are when the filings name Frank Cammisa, MD in the role, so the role may have started earlier or lasted longer.

Spine BioPharma, Inc.

Director

2022 – 2026 · New York, NY

Develops non-opioid, non-surgical treatments for people with pain-related disabilities.

Key Colleagues at Startups

The people Frank Cammisa, MD works with at each company, as listed on that company's latest Form D.

Sources

1. SECSpine BioPharma, Inc. Form D, filed Jun 5, 2026